Vertex Pharmaceuticals Non-GAAP EPS of $3.89 beats by $0.01, revenue of $2.49B beats by $70M
Vertex Pharmaceuticals press release  (NASDAQ:VRTX): Q2  Non-GAAP EPS of $3.89  beats by $0.01.
Revenue of $2.49B (+14% Y/Y)  beats by $70M.
Company raises full year 2023 product revenue guidance to $9.7 to $9.8 billionÂ vs $9.75B consensus